I  U  P  A  C

 

 

 

News & Notices

Organizations & People

Standing Committees

Divisions

Projects

Reports

Publications
. . CI
. . PAC
. . Macro. Symp.

. . Books
. . Solubility Data

Symposia

AMP

Links of Interest

Search the Site

Home Page

 

Pure Appl. Chem. 76(5), 941-950, 2004

Pure and Applied Chemistry

Vol. 76, Issue 5

Neuropeptide mimetics for pain management

A. W. Lipkowski, A. Misicka, D. B. Carr, G. Ronsisvalle, D. Kosson, and I. Maszczynska Bonney

Medical Research Centre, Polish Academy of Sciences, 02106 Warsaw, Poland; Department of Chemistry, Warsaw University, 02-093 Warsaw, Poland; Tufts-New England Medical Center, Boston, MA 02111, USA; Department of Pharmaceutical Sciences, University of Catania, 95125 Catania, Italy; Department of Anesthesia and Intensive Care, Medical School, Warsaw, Poland

Abstract: The discovery of numerous endogenous neuropeptides that participate in the formation, transmission, modulation, and perception of pain signals offers numerous strategies for the development of new analgesics. Nevertheless, the same research has not yet replaced
opioids as the gold standard of pain treatment. Therefore, one possible avenue of drug development may shift interest from searching for receptor-selective opioids to creating an arsenal of drugs that target multiple opioid and non-opioid sites simultaneously. The presented short review focuses on the development of potential analgesic peptidomimetic compounds based upon opioid neuropeptides and substance P.

*Lecture presented at the Polish-Austrian-German-Hungarian-Italian Joint Meeting on Medicinal Chemistry, Kraków, Poland, 15-18 October 2003. Other presentations are published in this issue, pp. 907 -1032.


Page last modified 8 July 2004.
Copyright © 2004 International Union of Pure and Applied Chemistry.
Questions or comments about IUPAC, please contact, the Secretariat.
Questions regarding the website, please contact web manager.